Agroaceite, a subsidiary of AgroAmerica Tropical Oil Holding Corp. is Awarded the Community Impact RSPO Excellence Award 2019
20.11.2019 19:31:00 EET | Business Wire | Press release
Agroaceite, a subsidiary of AgroAmerica, was awarded the Community Impact RSPO Excellence Award 2019 for the implementation of the "Human Development Center" project (HDC).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191120005702/en/
Agroaceite, a subsidiary of AgroAmerica Tropical Oil Holding Corp. was awarded the Community Impact RSPO Excellence Award 2019 for the implementation of the "Human Development Center" project (HDC). The subsidiary has donated 10ha of plantations for the construction of the project that is comprised of a Medical Clinic and school for children of workers in Southwestern Guatemala. "It reflects the company's comprehensive vision to provide access to high-quality education & health coverage," Gustavo Bolaños -AgroAmerica COO- (Photo: Business Wire)
The HDC project is based on the Sustainable Development Goals ; and is executed by Agroaceite, a subsidiary of AgroAmerica Tropical Oil Holding Corp; which has donated 10ha of plantations for the construction of the project that is comprised of a Medical Clinic and school for children of workers:
• Medical Clinic: Conducted in partnership with the University of Colorado to promote integral health access. It opened in 2014 and has impacted more than 27 thousand patients in the Southwestern region of Guatemala. It also runs community programs, in which 3,343 children and 1,977 women have participated, to reduce maternal and infant mortality and improve the nutritional status of the area.
• School for children of workers: Established to raise the academic level of the area, the school has obtained regional recognition for academic performance and pedagogical methodology.
"It reflects the company's comprehensive vision to provide access to high-quality education & health coverage," Gustavo Bolaños -AgroAmerica COO-.
With more than 4,000 members from 92 countries around the world, the RSPO organized, for the first time, the RSPO 2019 Excellence Awards Ceremony to recognize their member’s contributions to sustainable production with practices that go beyond the regulations standards.
The award was presented during the seventeenth Annual RSPO Conference -RT17- held in Bangkok, Thailand. A jury of experts in the palm oil and sustainability sector evaluated RSPO member’s projects in 5 categories: Human Rights and Labour Initiative, Conservation Leadership, Smallholder Impact Programme, Community Impact, and Outstanding Achievement.
About AgroAmerica Tropical Oil Holding Corp.:
It is AgroAmerica’s business unit that engages in the production and marketing of Tropical Oil products.
AgroAmerica is committed to contributing to the well being of people through innovation and technological investment for the development of products, services, programs and projects that promote welfare in the company’s stakeholders.
Visit us: https://agroamerica.com/en/
----------------------------------------------------------------
About Agroaceite:
Agroaceite is the fourth company in the world, the third in Latin America, and the first in Central America to obtain the RSPO Next certification, which includes several advanced criteria that exceed the RSPO standard.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191120005702/en/
Contact information
Javier Aguirre
Corporate Director
comunicacion@agroamerica.com
(502) 2420-9600
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mobius Renewables Acquires Air Liquide’s Biogas Production Activities in the United States, France, Norway, and Sweden4.5.2026 09:45:00 EEST | Press release
Mobius Renewables today announced the closing of the acquisition of Air Liquide’s biogas production activities in the United States, France, Norway, and Sweden. The acquisition includes six operating landfill gas-to-RNG (Renewable Natural Gas) sites in the U.S., five operating farm waste sites in France, and a 51% interest in Redo Biosolutions with production and distribution assets across Norway and Sweden. The acquired portfolio will be a meaningful addition to Mobius Renewables (“the Company”), a global, vertically integrated low carbon fuels platform established in December 2025 by funds managed by IFM Investors to accelerate the development, production, distribution, and commercialization of RNG at scale across North America and Europe. The Company is headquartered in Houston, Texas with additional offices in the United States, France, Norway, and Sweden. With this transaction, the establishment of Mobius Renewables is complete, and GreenGasUSA and the acquired portfolio will oper
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease2.5.2026 00:28:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meeting the evolving needs of patients with myeloproliferative neoplasms (MPNs) and GVHD,” said Bill Meury, Chief Executive Officer, Incyte. “Jakafi XR offers appropriate patients and physicians a once-daily option, expanding choice without changing the well-
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 19:08:00 EEST | Press release
A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines were switched off and everyday life took center stage. The night also celebrated the start of the new partnership between Barilla and the Visa Cash App Racing Bulls (VCARB) Formula 1® Team, a meeting of
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 13:07:00 EEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 02:17:00 EEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom